These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32265922)

  • 1. Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity.
    Honkanen J; Vuorela A; Muthas D; Orivuori L; Luopajärvi K; Tejesvi MVG; Lavrinienko A; Pirttilä AM; Fogarty CL; Härkönen T; Ilonen J; Ruohtula T; Knip M; Koskimäki JJ; Vaarala O
    Front Immunol; 2020; 11():468. PubMed ID: 32265922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
    Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
    Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota composition differs between children with β-cell autoimmunity and those without.
    de Goffau MC; Luopajärvi K; Knip M; Ilonen J; Ruohtula T; Härkönen T; Orivuori L; Hakala S; Welling GW; Harmsen HJ; Vaarala O
    Diabetes; 2013 Apr; 62(4):1238-44. PubMed ID: 23274889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
    Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.
    Mustonen N; Siljander H; Peet A; Tillmann V; Härkönen T; Ilonen J; Hyöty H; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):293-299. PubMed ID: 28597957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
    Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
    Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
    Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
    Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.
    Siljander HT; Simell S; Hekkala A; Lähde J; Simell T; Vähäsalo P; Veijola R; Ilonen J; Simell O; Knip M
    Diabetes; 2009 Dec; 58(12):2835-42. PubMed ID: 19755526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.
    Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M
    Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
    Strollo R; Vinci C; Napoli N; Pozzilli P; Ludvigsson J; Nissim A
    Diabetologia; 2017 Aug; 60(8):1467-1474. PubMed ID: 28526919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life.
    Ilonen J; Hammais A; Laine AP; Lempainen J; Vaarala O; Veijola R; Simell O; Knip M
    Diabetes; 2013 Oct; 62(10):3636-40. PubMed ID: 23835325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
    Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.